High Throughput Screening Facility

The WEHI HTS facility​ allows screening of various libraries including 250,000 diverse, “lead-like” small molecules, with synthetically amenable structures and high diversity, as per Tanimoto similarity analysis (T≤0.85). 89% of the compounds are Lipinski compliant and are subject to an open access intellectual property policy, i.e. full transfer of IP rights to customer.

Screening infrastructure is highly advanced and offers among the highest throughput screening available in Australia.

 

Contact:  Dr Helene Jousset

Email:  High throughput screening facility

Phone:  +61 (0)3 9345 2555 (general enquiries)

Level 14, 330 Collins St

Melbourne 3000 VIC

Call

T: +61 (07) 3735 4433

©2019 Therapeutic Innovation Australia

Enabled by

NCRIS-PROVIDER-RGB-REV.png